SmurfVA's Random Picks

[Ned Serious]

CYTR News : CytRx to present updated aldoxorubicin study results at AACR meeting

link: http://www.theflyonthewall.com/permalinks/entry.php/CYTRid1988125/CYTR-CytRx-to-present-updated-aldoxorubicin-study-results-at-AACR-meeting

CytRx announced that positive preclinical results from an in vivo study of aldoxorubicin in an animal model of glioblastoma will be presented at the American Association for Cancer Research Annual Meeting being held April 5-9, 2014 in San Diego, CA. CytRx announced data from the trial, which demonstrated that aldoxorubicin significantly increased survival almost 2½ fold compared to doxorubicin treatment in an in vivo xenograft tumor model employing growth of human glioblastoma multiforme tumors in mouse brains. Aldoxorubicin, but not doxorubicin, also demonstrated preferential accumulation and prolonged retention in the tumor tissue. These data, combined with aldoxorubicin’s favorable safety profile, support the current evaluation of aldoxorubicin as a treatment for patients with GBM tumors.

Best of Luck